Radiopharmaceutical firm IBA Molecular has made several key additions to its U.S. management team.
The company named Anthony Stagnolia as chief operating officer and Peter Burke as vice president of sales and marketing.
Stagnolia has more than 20 years of manufacturing and leadership experience, most recently as CEO for PETNet Solutions, IBA said.
Burke brings more than 12 years of experience in nuclear medicine and molecular imaging to the firm, holding leadership and general management positions in the pharmacy and nuclear medicine industries, according to IBA.
